Laser Artery Disease Therapy: FDA approves next-gen laser atherectomy catheter

    Feb. 17, 2016
    Spectranetics (Colorado Springs, CO) has received FDA 510(k) clearance for its Turbo-Power laser atherectomy catheter to treat in-stent restenosis (ISR).

    Spectranetics (Colorado Springs, CO) has received FDA 510(k) clearance for its Turbo-Power laser atherectomy catheter to treat in-stent restenosis (ISR). The company notes that laser atherectomy is driving a new standard of care for treatment of coronary artery disease, with improved clinical outcomes. The tool uses vaporizing technology to maximize luminal gain-it debulks the lesion in a single step and offers remote automatic rotation for precise directional control.

    About the Author

    Barbara Gefvert | Editor-in-Chief, BioOptics World (2008-2020)

    Barbara G. Gefvert has been a science and technology editor and writer since 1987, and served as editor in chief on multiple publications, including Sensors magazine for nearly a decade.

    Continue Reading

    Sponsored Recommendations

    March 31, 2025
    Enhance your remote sensing capabilities with Chroma's precision-engineered optical filters, designed for applications such as environmental monitoring, geospatial mapping, and...
    March 31, 2025
    Designed for compatibility with a wide range of systems, Chroma's UV filters are engineered to feature high transmission, superior out-of-band blocking, steep edge transitions...
    March 31, 2025
    Discover strategies to balance component performance and system design, reducing development time and costs while maximizing efficiency.
    March 31, 2025
    Explore the essential role of optical filters in enhancing Raman spectroscopy measurements including the various filter types and their applications in improving signal-to-noise...

    Voice your opinion!

    To join the conversation, and become an exclusive member of Laser Focus World, create an account today!